CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma
Liver cancer, especially hepatocellular carcinoma, is an important cause of cancer-related death, and its incidence is increasing worldwide. Nano drug delivery systems have shown great promise in the treatment of cancers. In order to improve their therapeutic efficacy, it is very important to realiz...
Saved in:
Main Authors: | Jinhu Liu (Author), Weiwei Mu (Author), Tong Gao (Author), Yuxiao Fang (Author), Na Zhang (Author), Yongjun Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells
by: Maedeh Koohi Moftakhari Esfahani, et al.
Published: (2021) -
Effects of Absorption Kinetics on the Catabolism of Melatonin Released from CAP-Coated Mesoporous Silica Drug Delivery Vehicles
by: Irene Moroni, et al.
Published: (2021) -
Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
by: Shanshan Liu, et al.
Published: (2018) -
Immobilization of Metronidazole on Mesoporous Silica Materials
by: Klára Szentmihályi, et al.
Published: (2022) -
Mesoporous silica nanoparticles for drug and gene delivery
by: Yixian Zhou, et al.
Published: (2018)